In This Article:
- By insider
CEO of Arcus Biosciences Inc (RCUS) Terry J Rosen bought 9,289 shares of RCUS on 08/24/2018 at an average price of $13.45 a share. The total cost of this purchase was $124,937.
Arcus Biosciences Inc is a clinical-stage biopharmaceutical company which focuses on developing and commercializing cancer immunotherapies. Arcus Biosciences Inc has a market cap of $599.280 million; its shares were traded at around $13.48 .
-
Warning! GuruFocus has detected 8 Warning Signs with MDT. Click here to check it out.
-
The intrinsic value of RCUS
CEO Recent Trades:
-
CEO Terry J Rosen bought 9,289 shares of RCUS stock on 08/24/2018 at the average price of $13.45. The price of the stock has increased by 0.22% since.
-
CEO Terry J Rosen bought 8,891 shares of RCUS stock on 08/21/2018 at the average price of $13.24. The price of the stock has increased by 1.81% since.
-
CEO Terry J Rosen bought 28,401 shares of RCUS stock on 08/16/2018 at the average price of $12.64. The price of the stock has increased by 6.65% since.
-
CEO Terry J Rosen bought 9,929 shares of RCUS stock on 08/13/2018 at the average price of $11.87. The price of the stock has increased by 13.56% since.
Directors and Officers Recent Trades:
-
President Juan C. Jaen bought 10,000 shares of RCUS stock on 08/13/2018 at the average price of $11.88. The price of the stock has increased by 13.47% since.
For the complete insider trading history of RCUS, click here
.This article first appeared on GuruFocus.
-
Warning! GuruFocus has detected 8 Warning Signs with MDT. Click here to check it out.
-
The intrinsic value of RCUS